pharmaceuticals
0
Ilesol Pharmaceuticals Launches Three New Skincare Products
0

Ilesol Pharmaceuticals has launched three new skincare products as a part of our Skin Greens collection. The new products are Skin Greens Heat Is On ...

0
Worldwide Hemp Regulation – Ilesol Pharmaceuticals
0

Blog Posted on March 22, 2023 | Last updated on May 13, 2024 ...

0
Can you ditch those Pharmaceuticals?
0

Sure hope so. For medication substitution, a survey of people in Los Angeles found 60% reported using cannabis to replace medications (sedatives/sleep aids, ...

0
Ilesol Pharmaceuticals Expands its Product Line with Botanical Extracts, Functional Mushrooms, and Customized Food Supplements
0

Ilesol Pharmaceuticals is proud to announce the launch of new products in our line-up and brand new web site. In addition to our current product ...

0
SYNBIOTIC acquires Ilesol Pharmaceuticals! – Ilesol Pharmaceuticals
0

Enormous competitive advantages through cannabinoid extracts and isolates from own production. The German industrial hemp and cannabis group ...

0
Flavonoid-rich foods SLASH DIABETES RISK by 28% as study reveals plant compounds outperform pharmaceuticals
0

A groundbreaking UK Biobank study of 113,097 participants reveals that consuming just six servings of flavonoid-rich foods daily—packed with potent ...

0
Worm-free Horses Without Pharmaceuticals – Livestock
0

Worm-free Horses Without Pharmaceuticalsby Stuart Pattison of Devon, UKThere are three main classes of chemical sheep wormers used in Britain. Sheep worms ...

0
BIS Initiates 232 Investigations of Pharmaceuticals and Semiconductors
0

The U.S. Department of Commerce Bureau of Industry and Security (BIS) announced the initiation of investigations into the effects on U.S. national ...

0
Ironwood Pharmaceuticals: Setting A Strong Foundation For A Return To Growth
0

Ironwood Pharmaceuticals: Setting A Strong Foundation For A Return To Growth

0
Generic Drugmaker Amneal Clocks Mixed Q4 Earnings, Plans Expansion In High-Growth Areas Like Weight Loss Products, Biosimilars – Amneal Pharmaceuticals (NASDAQ:AMRX)
0

On Friday, Amneal Pharmaceuticals Inc. AMRX reported fourth-quarter adjusted EPS of 12 cents, down from 14 cents a year ago and missing the consensus of ...

Som2ny Network
Logo
Compare items
  • Total (0)
Compare
0
Shopping cart